Protocol to Obtain Blood for Discovery of Novel Biomarkers and Potential Therapeutic Targets in Chronic Lymphocytic Leukemia
NCT01069432 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2018-03-19
Summary
The purpose of this study is to collect a blood sample from patients with Chronic Lymphocytic Leukemia (CLL) and from volunteers without CLL.
Conditions
Interventions
- OTHER
-
No Intervention
No Intervention
Sponsors & Collaborators
-
Dartmouth-Hitchcock Medical Center
lead OTHER
Principal Investigators
-
Christopher H Lowrey, MD · Dartmouth-Hitchcock Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2011-02-28
- Completion
- 2011-02-28
Countries
- United States
Study Locations
More Related Trials
-
Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients
NCT07162532 ·Status: NOT_YET_RECRUITING
-
Collecting and Storing Blood Samples From Patients With Cancer
NCT00900120 ·Status: WITHDRAWN
-
Identification of Key Blood Molecular Markers for Immunotherapy
NCT00507702 ·Status: TERMINATED
-
Blood Biomarker Signature in Glioma
NCT03698201 ·Status: TERMINATED
-
Memory Phenotype and PD-1 Inhibition Response in Oral Cancer
NCT03862066 ·Status: TERMINATED
-
Liquid Biopsy Collection Study
NCT06068348 ·Status: ACTIVE_NOT_RECRUITING
-
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
NCT03050398 ·Status: TERMINATED ·Phase: PHASE3
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
NCT02474160 ·Status: RECRUITING
-
Pathogenesis of Hematologic Malignancies
NCT01728402 ·Status: ENROLLING_BY_INVITATION
-
Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
NCT01520246 ·Status: COMPLETED
-
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
NCT00897767 ·Status: COMPLETED
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells
NCT01286883 ·Status: TERMINATED
-
Genomic Analysis of Patients With Chronic Lymphocytic Leukemia
NCT01346020 ·Status: ACTIVE_NOT_RECRUITING
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies
NCT03727009 ·Status: TERMINATED
-
Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia
NCT01626183 ·Status: COMPLETED
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell Growth
NCT01174615 ·Status: WITHDRAWN
-
Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
NCT00071045 ·Status: RECRUITING
-
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
NCT02269592 ·Status: RECRUITING
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
NCT03662204 ·Status: COMPLETED
-
Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia
NCT01016379 ·Status: COMPLETED
-
Biomarker Identification for Bladder Cancer Patients
NCT02053662 ·Status: TERMINATED
-
Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers
NCT00580203 ·Status: COMPLETED